C

CT Atlantic AG

10 employees

CT Atlantic AG is a swiss biotech company researches and develops novel, human-derived antibodies for the treatment of cancer.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Apps

Date founded

2008

Funding rounds raised

Total raised

$9M

from 1 investors over 1 rounds

C

CT Atlantic AG raised $9M on January 12, 2009

Investors: HS Lifescience

FAQ